Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-6,134
Closed -$346K 78
2014
Q2
$346K Sell
6,134
-335
-5% -$17.6K 0.17% 63
2014
Q1
$333K Buy
6,469
+395
+7% +$20K 0.18% 67
2013
Q4
$321K Buy
6,074
+30
+0.5% +$1.47K 0.17% 52
2013
Q3
$270K Sell
6,044
-120
-2% -$5.32K 0.17% 59
2013
Q2
$255K Buy
+6,164
New +$270K 0.17% 60

Other funds holding ABBV

CIM LLC's ABBV Position: Q3 2014 in Review

CIM LLC sold out of AbbVie (ABBV) in Q3 2014, closing a stake of 6,134 shares — an estimated $346K sold.

CIM LLC first reported a position in ABBV in Q2 2013 and held it in 5 quarters. The position peaked at $346K in Q2 2014. 1,502 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • CIM LLC reported no remaining AbbVie position as of Q3 2014 after selling out during the quarter.
  • CIM LLC sold 6,134 AbbVie shares in Q3 2014, an estimated $346K.
  • CIM LLC first reported a position in AbbVie in Q2 2013 and held it in 5 quarters.
  • CIM LLC's AbbVie position peaked at $346K in Q2 2014.
  • 1,502 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on CIM LLC's 13F filing for Q3 2014, filed 28 Oct 2014.